Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria

Clinical Oncology : a Journal of the Royal College of Radiologists
Myo MinAllan Fowler

Abstract

To evaluate the prognostic utility of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography-computed tomography (FDG PET-CT) carried out in the third week (iPET) and after completion (pPET) of definitive radiation therapy in patients with mucosal primary head and neck squamous cell carcinoma (MPHNSCC) and to investigate the optimal visual grading criteria for therapy response assessment. Sixty-nine consecutive patients with newly diagnosed MPHNSCC treated with radical radiation therapy with or without systemic therapy underwent staging. PET-CT, iPET and pPET were included. All PET-CT images were reviewed by using a visual grading system to assess metabolic response for primary tumour: 0 = similar to adjacent background blood pool activity; 1 = more than background but < mediastinal blood pool; 2 ≥ mediastinal blood pool and < liver; 3 ≥ liver; and 4 ≥ brain. The results were correlated with locoregional recurrence-free survival (LRFS), disease-free survival (DFS) and overall survival, using Kaplan-Meier analysis. The median follow-up was 28 months (range 6-62), the median age was 61 years (range 39-81) and AJCC 7th edition clinical stage II, III and IV were six, 18 and 45 patients, respectively. The optimal threshold ...Continue Reading

References

Jul 6, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M G PoulsenQ Walker
Mar 6, 2010·The Lancet Oncology·June CorryDanny Rischin
Oct 12, 2010·International Journal of Radiation Oncology, Biology, Physics·Gaëtane CeulemansHendrik Everaert
Feb 26, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Maria HentschelKlaus Zöphel
Aug 20, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Tejpal GuptaAshwini Budrukkar
Mar 31, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Paola CastaldiVincenzo Valentini
Mar 14, 2013·Imaging in Medicine·Vasavi PaidpallyRathan M Subramaniam
Apr 23, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kyoungjune PakDong Soo Lee
Jun 21, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Charles MarcusRathan M Subramaniam
Jul 22, 2014·The Laryngoscope·Shang-Wen ChenChia-Hung Kao

❮ Previous
Next ❯

Citations

Jun 6, 2018·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Olga Hamming-VriezeWouter V Vogel
Apr 4, 2021·Journal of Clinical Medicine·Chen-Chi WangKai-Li Liang
Nov 1, 2020·Clinical Oncology : a Journal of the Royal College of Radiologists·C PatersonC N Rumley
Jun 4, 2019·Clinical Oncology : a Journal of the Royal College of Radiologists·S HargreavesM Evans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.